This brand name is authorized in Lithuania, Poland, Romania
The drug LOKREN contains one active pharmaceutical ingredient (API):
|
1
Betaxolol
UNII 6X97D2XT0O - BETAXOLOL HYDROCHLORIDE
|
|
Betaxolol is a cardioselective Beta1 receptor blocker which, when applied topically to the eye, lowers intraocular pressure. It is thought to produce this effect by reducing the rate of production of aqueous humour. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C07AB05 | Betaxolol | C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1003262, 1034675, 1074623, 1075478 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100039542, 100324343, 100325762, 100356828, 100384351, 100424056, 100427066, 100436875 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W67248001, W67248002, W67248003 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
